Skip to content
The Mumbai

Indian Patent Office Rejects TB Drug Patent, Boosting Push For Affordable MDR-TB Treatment

Indian Patent Office Rejects TB Drug Patent, Boosting Push For Affordable MDR-TB Treatment
Photo: Free Press Journal · view original

Mumbai, October 27, 2026: In a significant step towards making treatment more affordable for patients with drug-resistant tuberculosis (MDR-TB), the Indian Patent Office has rejected a patent application filed by the Global Alliance for TB Drug Development (TB Alliance). The office upheld objecti...

Sources and story details